ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.518,03
-0,44%
S&P 500
5.644,50
0,24%
Dow Jones
40.791,94
1,44%
Euro vs US Dollar
1,08846
-0,14%
Bitcoin
64.477,58
-0,58%
Registration Strip Icon for alerts Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. AstraZeneca PLC (AZN)

  7. AstraZeneca PLC (AZN) News

AZN

AstraZeneca (AZN)

AstraZeneca PLC
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NASDAQ:AZN
DatumZeitQuelleÜberschriftSymbolFirma
16/07/202108h40Dow Jones NewsAstraZeneca Says US FDA Advisory Committee Has Voted Against Approval of RoxadustatNASDAQ:AZNAstraZeneca PLC
16/07/202101h01PR Newswire (US)Moderna Set to Join S&P 500NASDAQ:AZNAstraZeneca PLC
14/07/202111h11Dow Jones NewsAstraZeneca Says $39 Billion Alexion Deal Set for Completion After UK Clearance -- UpdateNASDAQ:AZNAstraZeneca PLC
14/07/202108h30Dow Jones NewsUK Regulator Clears AstraZeneca's Alexion DealNASDAQ:AZNAstraZeneca PLC
13/07/202108h00GlobeNewswire Inc.HUTCHMED Announces First Commercial Sale of ORPATHYS® in China, Triggering a US$25 million Milestone Payment from AstraZenec...NASDAQ:AZNAstraZeneca PLC
12/07/202120h32Dow Jones NewsCorrection to Canadian Vaccine Donation ArticleNASDAQ:AZNAstraZeneca PLC
12/07/202120h00Dow Jones NewsCanada to Donate Nearly 18 Million AstraZeneca Doses to CovaxNASDAQ:AZNAstraZeneca PLC
09/07/202115h00GlobeNewswire Inc.EnWave Signs Material Transfer Agreement with AstraZeneca to Trial Radiant Energy Vacuum Technology for Pharmaceutical Dehydr...NASDAQ:AZNAstraZeneca PLC
08/07/202114h46Dow Jones NewsF-star Therapeutics in Licensing Deal with AstraZeneca; Shares UpNASDAQ:AZNAstraZeneca PLC
08/07/202114h00GlobeNewswire Inc.F-star Therapeutics Enters into Exclusive Licensing Agreement with AstraZeneca for Novel STING InhibitorsNASDAQ:AZNAstraZeneca PLC
08/07/202112h06Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:AZNAstraZeneca PLC
08/07/202108h35Dow Jones NewsAstraZeneca Granted FDA Priority Review for Asthma TreatmentNASDAQ:AZNAstraZeneca PLC
01/07/202117h21Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:AZNAstraZeneca PLC
29/06/202116h57Edgar (US Regulatory)Annual Report of Employee Stock Plans (11-k)NASDAQ:AZNAstraZeneca PLC
28/06/202116h43Dow Jones NewsAstraZeneca Says First Dose of Its Covid-19 Vaccine Induces Immunity for at Least One YearNASDAQ:AZNAstraZeneca PLC
28/06/202108h47Dow Jones NewsAstraZeneca's Forxiga Recommended in EU for Chronic Kidney DiseaseNASDAQ:AZNAstraZeneca PLC
25/06/202120h45Dow Jones NewsAstraZeneca Reports Positive Results From Once-Weekly Exenatide Trial in AdolescentsNASDAQ:AZNAstraZeneca PLC
24/06/202113h18Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:AZNAstraZeneca PLC
24/06/202108h35Dow Jones NewsAstraZeneca's Lynparza Drug Approved in China for Prostate CancerNASDAQ:AZNAstraZeneca PLC
23/06/202108h36Dow Jones NewsAstraZeneca's Orpathys Conditionally Approved by China for Lung Cancer PatientsNASDAQ:AZNAstraZeneca PLC
22/06/202108h37Dow Jones NewsAstraZeneca: Koselugo Conditionally Approved in EU for Children With NF1NASDAQ:AZNAstraZeneca PLC
18/06/202116h10Dow Jones NewsAstraZeneca Ordered to Deliver Vaccine Doses to EU Amid Lawsuit -- UpdateNASDAQ:AZNAstraZeneca PLC
18/06/202114h37Dow Jones NewsAstraZeneca Welcomes Court Ruling on Supply of Its Covid-19 Vaccine to EuropeNASDAQ:AZNAstraZeneca PLC
18/06/202100h14Dow Jones NewsCanada Vaccine Panel Recommends Against AstraZeneca PLC for Second DoseNASDAQ:AZNAstraZeneca PLC
17/06/202109h54Dow Jones NewsRedx Pharma Gets $4 Million as Milestone Payment From AstraZenecaNASDAQ:AZNAstraZeneca PLC
15/06/202112h50Dow Jones NewsAstraZeneca's Covid-19 Drug Fails to Meet Primary Goal in Trial -- UpdateNASDAQ:AZNAstraZeneca PLC
15/06/202108h51Dow Jones NewsAstraZeneca: AZD7442 Trial for Prevention of Symptomatic Covid-19 Didn't Meet Primary GoalNASDAQ:AZNAstraZeneca PLC
15/06/202108h35Dow Jones NewsAstraZeneca: Covid-19 Vaccine Is 92% Effective Against Indian VariantNASDAQ:AZNAstraZeneca PLC
09/06/202123h12Dow Jones NewsNew Study Finds Slightly Elevated Risk of Bleeding Disorders After AstraZeneca Vaccine -- UpdateNASDAQ:AZNAstraZeneca PLC
09/06/202119h45Dow Jones NewsNew Study Finds Slightly Elevated Risk of Bleeding Disorders After AstraZeneca VaccineNASDAQ:AZNAstraZeneca PLC
 Showing the most relevant articles for your search:NASDAQ:AZN

Kürzlich von Ihnen besucht

AQSE
IPRV.GB
iShares Listed Private E...
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten